LOVELLA MEDILO: Open Payments
NPI 1659930485 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,682 in 69 payments from 8 companies in 2025. Trend: 2023 $1,759 · 2024 $1,772 · 2025 $2,682
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 8 | $1,236 |
| Boston Scientific Corporation | 12 | $471 |
| Forte Bio-Pharma LLC | 29 | $464 |
| Curonix LLC | 3 | $182 |
| SCILEX PHARMACEUTICALS INC. | 13 | $177 |
| Stryker Corporation | 1 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Abbott Laboratories | 1 | $17 |
Products named: IFUSE IMPLANT SYSTEM, PROLATE, General - Pain Management, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, WaveWriter Alpha Prime 16, MILD DEVICE KIT, ELYXYB - CELECOXIB, ZTLido.
Industry payments across CA — which companies pay providers there.
